Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Novavax, Inc.
  6. Calendar
    NVAX   US6700024010

NOVAVAX, INC.

(NVAX)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-31 pm EST
10.91 USD   +2.44%
05:47pFactbox-What ending the U.S. COVID health emergency means for your pocket
RE
01/26FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/26Novavax needs 6 months to produce annual COVID shots that match new variants
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart NOVAVAX, INC.
Upcoming events on NOVAVAX, INC.
02/27/23 FY 2022 Earnings Release (Projected)
05/08/23 Q1 2023 Earnings Release (Projected)
08/03/23 Interim 2023 Earnings Release (Projected)
11/02/23 Q3 2023 Earnings Release (Projected)
Past events on NOVAVAX, INC.
01/09/23 | 08:15pm JP Morgan Healthcare Conference
12/07/22 | 09:10am BofA Securities Virtual Biotech SMID Cap Conference
11/16/22 | 03:35am Jefferies London Healthcare Conference
11/08/22 | 04:30pm Q3 2022 Earnings Call
11/08/22 Q3 2022 Earnings Release
10/22/22 | 12:15pm IDWeek Conference - Shinde, V
10/22/22 | 10:15am IDWeek Conference
10/20/22 | 01:45pm IDWeek Conference - Áñez, G
10/13/22 | 08:30am World Vaccine Congress
10/12/22 | 02:30am World Vaccine Congress
Past dividends on NOVAVAX, INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
31,2
28,7
8,5%
34,3
35,3
-2,8%
18,7
11,8
58%
476
398
19%
1 146
1 263
-9,3%
 
1 947
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-154
-149
-3,8%
-166
-158
-4,6%


 


 


 
 
-455
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-172
-168
-2,1%
-174
-172
-1,3%
-130
-121
-7,5%
-417
-393
-6,0%
-1 687
-979
-72%
 
-480
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-184
-180
-2,3%
-185
-182
-1,4%
-133
-128
-3,9%
-418
-383
-9,3%
-1 715
-1 007
-70%
 
-548
 
Net income
M $
Released
Forecast
Spread
-184
-180
-2,0%
-185
-182
-1,4%
-133
-130
-2,4%
-418
-383
-9,3%
-1 744
-1 021
-71%
 
-535
 
EPS
$
Released
Forecast
Spread
-12,6
-12,4
-1,5%
-10,0
-10,2
2,4%
-5,51
-5,42
-1,6%
-7,27
-6,58
-11%
-23,4
-13,7
-71%
 
-7,12
 
Announcement Date03/14/201803/18/201903/11/202003/01/202102/28/2022-
Quarterly results
Fiscal Period : December2021 Q32021 Q42022 Q12022 Q22022 Q32022 Q4
Sales
M $
Released
Forecast
Spread
179
347
-49%
222
332
-33%
704
845
-17%
186
1 017
-82%
735
555
32%
 
365
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 


 


 


 
-119
310
-138%
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-307
-275
-12%
-825
-114
-627%
209
247
-15%
-483
486
-199%
-127
139
-192%
 
-93,3
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-316
-276
-15%
-830
-118
-605%
206
242
-15%
-509
495
-203%
-166
93,2
-278%
 
-91,6
 
Net income
M $
Released
Forecast
Spread
-322
-282
-14%
-846
-124
-584%
203
213
-4,7%
-510
449
-214%
-169
132
-227%
 
-80,4
 
EPS
$
Released
Forecast
Spread
-4,31
-3,73
-16%
-11,2
-1,80
-520%
2,56
2,65
-3,5%
-6,53
5,50
-219%
-2,15
1,64
-231%
 
-1,14
 
Announcement Date11/04/202102/28/202205/09/202208/08/202211/08/2022-
Previous year Next Year
Upcoming sector events for NOVAVAX, INC.
More events
Past sector events for NOVAVAX, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise